News
EUROPEAN shares started the week on a positive note on Monday after the United States and China agreed to temporarily slash ...
PhRMA, which gave $1 million to Trump's inaugural fund, warned against parts of Trump's drug pricing executive order.
US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...
During a live event, Shuo Ma, MD, PhD, discussed the outcomes of the BRUIN trial of pirtobrutinib in BTK inhibitor–pretreated ...
Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
As a Biden administration ban on so-called “junk fees” took effect Monday, Ticketmaster said it would start displaying the ...
The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...
Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results